| Grade 1 Meningioma studied in …STUDIED_INderived20 of 20show fewer |
|---|
| → studied in | NCT04082520Phase 2 · recruiting Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy · condition mapped ONTOLOGY_EXACT · 20 trials mapped (3 active) | — | — | Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659811Phase 2 · active not recruiting Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04278118NA · recruiting Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study · condition mapped CURATED_BROADER · 20 trials mapped (3 active) | — | — | Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125046Phase 2 · completed Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919750completed Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045110Phase 1/Phase 2 · completed Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045734Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Meningioma · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004078Phase 2 · completed Irinotecan in Treating Children With Refractory Solid Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110032Phase 1 · terminated Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Adult Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363272Phase 1 · completed Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma · condition mapped ALIAS · 20 trials mapped (3 active) | — | — | Childhood Grade 1 Meningioma | 1 | Observed | clinicaltrials | graph → |